Crossmark

Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study

Crossref DOI link: https://doi.org/10.1007/s11239-015-1301-8

Published Online: 2016-02-05

Published Print: 2016-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Wei

Goldberg, Robert J.

Anderson, Frederick A.

Cohen, Alexander T.

Spencer, Frederick A.
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (R01-HL70283)

National Institute of Aging (R01AG031083)
License Information

Text and Data Mining valid from 2016-02-05

Version of Record valid from 2016-02-05
More Information

Article History

First Online: 5 February 2016

Compliance with ethical standards

:

: Professor Anderson received research grants from Sanofi and The Medicines Company; he has served as a consultant to GlaxoSmithKline and Takeda Oncology on the design of outcomes studies. Dr. Cohen reports grants and personal fees from Bayer, Boehringer-Ingelheim, BMS, Daiichi, GSK, Johnson and Johnson, Pfizer, Portola, Sanofi and XO1, outside the submitted work. All other authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below